Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK

被引:31
|
作者
McLernon, David J. [1 ]
Bond, Christine M.
Lee, Amanda J.
Watson, Margaret C.
Hannaford, Philip C.
Fortnum, Heather [2 ]
Krska, Janet [3 ]
Anderson, Claire [2 ]
Murphy, Elizabeth [4 ]
Avery, Anthony [2 ]
机构
[1] Univ Aberdeen, Med Stat Team, Sect Populat Hlth, Aberdeen AB25 2ZD, Scotland
[2] Univ Nottingham, Nottingham NG7 2RD, England
[3] Liverpool John Moores Univ, Liverpool L3 5UX, Merseyside, England
[4] Univ Leicester, Leicester, Leics, England
关键词
adverse drug reaction reporting system; patient; questionnaire; personal narratives; INFORMATION;
D O I
10.1002/pds.2117
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose To describe the characteristics of patient reporters to the UK's Yellow Card Scheme (YCS) and the suspect drugs reported, and to determine patient views and experiences of making a Yellow Card report. Methods A questionnaire was developed for distribution by the Medicines and Healthcare products Regulatory Agency (MHRA) to all patients reporting through the YCS between March 2008 and January 2009. Associations between reporting method (online, postal and telephone) and questionnaire responses were examined using Pearson's Chi-squared test. Results Evaluable questionnaires were returned by 1362 out of 2008 reporters (68%). Respondents' median (IQR) age was 56.5 (43.0, 67.0) years, 910 (66.8%) were female, 1274 (93.5%) were white and 923 (67.8%) had at least a further education qualification. The most frequent reporting method was postal (59.8%), followed by online (32.8%) and telephone (6.3%). Online reporters were younger with a higher education level than those using other reporting methods. Most respondents, 1274 (93.6%), thought that the report was fairly or very easy to complete, although many identified the need for improvements to the system. One third (n = 448; 32.9%) expected feedback from the MHRA and 828 (60.8%) would have liked feedback. Almost all respondents (n = 1302; 95.6%) would report again. Conclusions The majority of patients found the current methods of reporting suspected ADRs easy to use and would recommend them to others. Different methods of reporting were used by different demographic subgroups of reporters. Improvements to the system, including the provision of feedback to reporters, could be made. Copyright (C) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:523 / 531
页数:9
相关论文
共 50 条
  • [21] Adverse Drug Reaction Reporting in the UKA Retrospective Observational Comparison of Yellow Card Reports Submitted by Patients and Healthcare Professionals
    David J. McLernon
    Christine M. Bond
    Philip C. Hannaford
    Margaret C. Watson
    Amanda J. Lee
    Lorna Hazell
    Anthony Avery
    [J]. Drug Safety, 2010, 33 : 775 - 788
  • [22] Reports to the UK Yellow Card Scheme 2000-2009 for medications used in paediatric rheumatology
    Daniel B Hawcutt
    Clare Pain
    Rachel Mulholland
    Lisa M Cann
    Gavin Cleary
    Michael W Beresford
    Eileen Baildam
    [J]. Pediatric Rheumatology, 9 (Suppl 1)
  • [23] A BRIEF REVIEW OF THE YELLOW CARD ADVERSE REACTION REPORTING SCHEME IN THE UNITED-KINGDOM
    BURTON, GH
    MANN, RD
    [J]. PHARMACOEPIDEMIOLOGY, VOL 1, 1989, : 121 - 132
  • [25] Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator
    Deslandes, Paul N.
    Bracchi, Robert
    Jones, Karen
    Haines, Kath E.
    Carey, Emma
    Adams, Alana
    Walker, Jenna
    Thomas, Alison
    Routledge, Philip A.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (08) : 3829 - 3836
  • [26] UK veterinary professionals' perceptions and experiences of adverse drug reaction reporting
    Davies, Heather
    Pinchbeck, Gina
    Noble, Peter-John M.
    Diesel, Gillian
    Pirmohamed, Munir
    Anderson, Nadine
    Killick, David R.
    [J]. VETERINARY RECORD, 2022, 191 (06) : no
  • [27] ADVERSE DRUG REACTION REPORTS
    MOORE, ND
    BIOUR, M
    LOUPI, E
    [J]. LANCET, 1986, 1 (8480): : 555 - 555
  • [28] How Do Patients Contribute to Signal Detection?A Retrospective Analysis of Spontaneous Reporting of Adverse Drug Reactions in the UK’s Yellow Card Scheme
    Lorna Hazell
    Victoria Cornelius
    Philip Hannaford
    Saad Shakir
    Anthony J. Avery
    [J]. Drug Safety, 2013, 36 : 199 - 206
  • [29] How Do Patients Contribute to Signal Detection? A Retrospective Analysis of Spontaneous Reporting of Adverse Drug Reactions in the UK's Yellow Card Scheme
    Hazell, Lorna
    Cornelius, Victoria
    Hannaford, Philip
    Shakir, Saad
    Avery, Anthony J.
    [J]. DRUG SAFETY, 2013, 36 (03) : 199 - 206